Last reviewed · How we verify
NCT04961398
Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements
trial testing OCT imaging in Normal Eyes in 9 participants. Completed in 24 June 2021.
24 June 2021
Quick facts
| Lead sponsor | Heidelberg Engineering GmbH |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 9 |
| Start date | 21 June 2021 |
| Primary completion | 24 June 2021 |
| Estimated completion | 24 June 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- OCT imaging
Conditions studied
- Normal Eyes — all drugs for Normal Eyes →
Sponsor
Heidelberg Engineering GmbH
Who can join
22 and older, any sex, with Normal Eyes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluation of effect of various OCT scan speeds and filters on parameter measurements.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04961398
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of OCT imaging
Trials testing the same drug.
- NCT07338461 — High Resolution Imaging OCT Study · NA · not yet recruiting
- NCT05964634 — Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia · unknown
- NCT03323307 — Low Cost OCT for Point of Care · NA · completed
- NCT01875783 — OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits · NA · completed
Other recruiting trials for Normal Eyes
Currently open trials in the same condition.
- NCT05844852 — P200TE US Reference Database Study · NA · active not recruiting
Other Heidelberg Engineering GmbH trials
Trials by the same sponsor.
- NCT07338461 — High Resolution Imaging OCT Study · NA · not yet recruiting
- NCT06397976 — The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study · terminated
- NCT05051813 — The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study · completed
- NCT04661124 — Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position · completed
- NCT04604002 — Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04961398 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Heidelberg Engineering GmbH
- Last refreshed: 16 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04961398.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing